US equities |
NVDA $239.68 ▲+2.45% SPCX $169.93 ▲+6.90% MU $1,061.93 ▼-1.21% TSLA $380.23 ▲+2.60% SNDK $1,700.00 ▼-1.16% MSFT $527.55 ▲+1.94% INTC $116.22 ▼-2.61% META $742.22 ▲+1.94%
FinancialContent

Articles published by Biodesix, Inc.

< Previous 1 2 3 4 Next >
News headline image
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix to Participate in Upcoming Investor Conferences
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix Announces First Quarter 2025 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX BIO BIO-B
News headline image
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix Announces Third Quarter 2024 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix to Participate in Three Investor Conferences in November
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
News headline image
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Present at Two Investor Conferences in September
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix Announces Second Quarter 2024 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Participate in Two Investor Conferences in June
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
News headline image
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
< Previous 1 2 3 4 Next >